Local

French biotech startup to establish its U.S. headquarters in Pittsburgh

By By Nate Doughty - Reporter, Pittsburgh Business Times

Wpxi Pittsburgh skyline

By By Nate Doughty - Reporter, Pittsburgh Business Times

PITTSBURGH — A French biotech startup that’s developing a novel drug to help treat Type 2 diabetes has announced plans to establish its U.S. headquarters in Pittsburgh.

To do so, AdipoPharma, which is based in the French city of Strasbourg, will build out its operations at a site within the former AGH Suburban hospital complex in Bellevue, which is also the home of a life sciences startup accelerator program from Innovation Works and Allegheny Health Network called AlphaLab Health.

AdipoPharma’s flagship PATAS drug aims to treat a patient’s resistance to insulin, one of the causes behind the disease. The startup also noted its drug marks “the first therapeutic breakthrough for Type 2 diabetes treatment in more than a decade.”

Read more at Pittsburgh Business Times.

TRENDING NOW:

  • WINTER WEATHER ADVISORY: Here’s what you can expect as 2 storms move into the Pittsburgh area
  • Post office employee steals mail truck, leads officers on wrong-way chase along I-79, police say
  • Business owner demands action from Pittsburgh Public Schools over student behavior at bus stop
  • VIDEO: Winter weather driving tips from AAA, PennDOT
  • DOWNLOAD the Channel 11 News app for breaking news alerts

    • IRS heads into new tax season with backlog from previous year

    ©2023 Cox Media Group

    Most Read